VAERS Explorer
Back to explore

Report #2868827

Received Oct 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
1.1 yrs
State
IN
Recovered
Unknown
Vaccinated
Oct 6, 2025
Onset
Oct 6, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
PNC15PNEUMO (VAXNEUVANCE)MERCK & CO. INC.4X019197OT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

no symptomatic events; a VAXNEUVANCE dose that was administered to a 13 month old patient that was expired on 8/30/2025; This spontaneous report was received from a Physician Assistant and refers to a 13-month-old patient of unknown gender. The patient's medical history, drug history, concurrent conditions and concomitant therapies were not reported. On 06-Oct-2025, the patient was vaccinated with an expired dose of Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE), which was the fourth dose administered to this patient, (lot #X019197, expiration date: 30-Aug-2025) (dose, route of administration and anatomical site were not provided) as prophylaxis (Expired product administered). There were no symptomatic events, no additional adverse events (No adverse event).